Molecular Med Tri-Con 2018
Date: February 11 - 16, 2018
Venue: Moscone South Convention Center, San Francisco, California, USA
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


View All Sponsors

Premier Sponsors

  • Beckman Coulter Life Sciences
  • Boston Healthcare
  • Clarivate Analytics
  • Menarini Silicon Biosystems
  • NanoString
  • Qorvo
  • Scientist
  • ScreenCell
  • SeraCare
  • Streck

Join over 3,700 drug discovery and development professionals worldwide at the 25th International Molecular Medicine Tri-Conference!

Since its debut in 1993, the annual Molecular Medicine Tri-Conference has become one of the world's leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma and academia from around the world. 

Why attend the Tri-Conference?

HEAR over 500 speakers from across all industries, all research fields, and from all over the world
CHOOSE from over 400 presentations and panel discussions
VIEW over 170 Scientific Posters
VISIT with over 200 companies in the exhibit hall
FIVE days of diverse and innovative sessions

Molecular Diagnostics

Personalized Diagnostics

Cancer Molecular Markers

Circulating Tumor Cells and Liquid Biopsy

Digital Pathology

Precision Medicine

PCR & NGS-Based Molecular Diagnostics

Clinical NGS Diagnostics

Genomic Sample Prep, Assay Development and Validation

Molecular Diagnostics for Infectious Disease

Precision Medicine

PCR & NGS-Based Molecular Diagnostics

Clinical NGS Diagnostics

Genomic Sample Prep, Assay Development and Validation

Cancer Molecular Markers

Circulating Tumor Cells and Liquid Biopsy

Cancer Immunotherapy

Combination Immunotherapy Design Models

Bioinformatics for Big Data

Integrated Pharma Informatics

New Frontiers in CRISPR-Based Gene Editing

Circulating Cell-Free DNA

Point-of-Care Diagnostics

Biomarkers for Cancer Immunotherapy

NGS Diagnostics: Knowledge Bases, Annotation and Interpretation

Microbiome-Based Precision Medicine - NEW

Commercialization of Molecular Diagnostics

Who Attends
View Agenda 2017
Media Partners